A subsidiary of AstraZeneca in China, along with a former leading executive and a senior employee, has been indicted on various charges by the prosecutor in Shenzhen. The investigation has
All posts tagged in astrazeneca
36Articles
AstraZeneca has announced plans to invest $15 billion in China by 2030, aiming to enhance its manufacturing capabilities and expand research and development. This announcement comes during a visit by
Speculation surrounding a potential merger between GlaxoSmithKline and AstraZeneca has gained traction as GSK’s leadership undergoes a transition. Analysts recently suggested that the appointment of Luke Miels as GSK’s new
Sir Pascal Soriot, chief executive of AstraZeneca, has come under scrutiny following revelations that his family invested in an organisation recognised as a significant partner of Britain’s largest public company.
AstraZeneca has recorded its highest quarterly revenue to date, achieving a ten per cent increase and surpassing analyst expectations. The FTSE 100 pharmaceutical group announced total third quarter revenue had
AstraZeneca, the United Kingdom’s most valuable publicly listed company, has secured the backing of leading shareholder advisory groups for its proposal to achieve a direct listing on the New York
AstraZeneca has announced a major shift in its transatlantic pricing strategy, pledging to sharply reduce the cost of its medicines in the United States following mounting political pressure. The pharmaceutical
The Prime Minister recently convened with Sir Pascal Soriot, the chief executive of AstraZeneca, at Downing Street to discuss the government’s efforts to bolster UK capital markets. This meeting came
Billions of pounds were added to the market value of British and global pharmaceutical companies on Wednesday following a major relief rally prompted by the Trump administration’s latest stance on
AstraZeneca, one of Britain’s leading pharmaceutical giants, has announced its intention to secure a direct listing on the New York Stock Exchange in a strategic move aimed at strengthening its
AstraZeneca, the United Kingdom’s most valuable listed business, has announced a pause on its planned £200 million expansion at the Cambridge research hub, dealing a substantial setback to the government’s
Multinational companies continue to confront growing criticism for their continued financial contributions to the Russian state more than three years after the invasion of Ukraine. A recent report by the
AstraZeneca has reported record second quarter revenues, propelled by robust oncology sales and expansion in the United States, surpassing City expectations. The pharmaceutical company’s total revenue rose by 11 per
AstraZenecas chief executive has described the pharmaceutical giant as a very American company following rising speculation about a potential shift of its main stock market listing from London to New
AstraZeneca has announced an ambitious plan to invest £50 billion in the United States by the end of the decade. This significant move is expected to bolster the company’s manufacturing
The potential departure of AstraZeneca from the London Stock Exchange would deliver a ‘devastating blow’ to British markets, former Chancellor Lord Lamont warned Parliament today. The Conservative peer emphasised that
